1Osanai T, Okada S, Sirato K, et al.Mitochondrial coupling factor 6 is present on the surface of human endothelial cells and is released by shear stress. Cireulation, 2001,104:3132.
2Li XL, Xing QC, Gao YY, et al. Plasma level of mitochondrial coupling factor 6 increases in patients with type 2 diabetes mellitus. Int J Cardiol, 2006, (Epub ahead of print).
3San-bao Chai, Yong-ming Hai, Xue-ming Li, et al. Plasma level of mitochondrial coupling factor 6 increases in patients with coronary heart disease. Circ J, 2007,71:693.
4Makoto Tanaka, Tomohiro Osanai, Reiichi Murakami, et al. Effect of vasoconstrictor coupling factor 6 on gene expression profile in human vascular endothelial cells: enhanced release of asymmetric dimethylarginine. Journal of Hypertension, 2006,24,489.
5Higuti T, Tsurumi C, Kawamara Y, et al. Molecular cloning of cDNA for the import precursor of human coupling factor 6 of H^+- ATP synthase in mitochondria. Biochem Biophys Res Commun, 1991,178:793.
6Moser TL. Angiostatin binds ATP synthase on the surface of human endothelial cells. Proc Natl Acad Sci USA, 1999,96: 2511.
7Sangawa H, Himeda T, Shibata H, et al. Gene expression of subunit c (P1), subunit c(P2), and oligomycin sensitivity-conferring protein may play a key role in biogenesis of H^+-ATP synthase in various rat tissues. J Biol Chem, 1997,272:6034.
8Osanai T, Tamada T, Kamada T, et al. Mitochondrial coupling factor 6 as a potent endogenous vasoconstrictor. J Clin Invest, 2001,108(7):1023.
